Graphite Bio (GRPH) News Today → America’s worst nightmare? (From Porter & Company) (Ad) Free GRPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisDividendEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 22, 2024 | marketbeat.comTrading was temporarily halted for "GRPH" at 07:03 PM with a stated reason of "News pending."March 21, 2024 | finance.yahoo.comLENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate ProgressMarch 20, 2024 | marketbeat.comGraphite Bio Stock Set to Reverse Split on Friday, March 22nd (NASDAQ:GRPH)Graphite Bio, Inc. (NASDAQ:GRPH - Free Report)'s stock is going to reverse split before the market opens on Friday, March 22nd. The 1-7 reverse split was announced on Friday, March 22nd. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, March 22nd.March 15, 2024 | finance.yahoo.comGRPH Mar 2024 5.000 putMarch 15, 2024 | seekingalpha.comVERI, STI and VERB among mid-day moversMarch 15, 2024 | finance.yahoo.comGRPH Mar 2024 7.500 callMarch 15, 2024 | marketbeat.comGraphite Bio, Inc. Declares Dividend of $1.03 (NASDAQ:GRPH)Graphite Bio, Inc. (NASDAQ:GRPH) announced a dividend on Friday, March 15th. Shareholders of record on Monday, March 18th will be given a dividend of 1.03 per share on Thursday, March 21st. This represents a yield of 28.93%. The ex-dividend date is Friday, March 15th.March 15, 2024 | marketbeat.comTrading was temporarily halted for "GRPH" at 07:03 PM with a stated reason of "News pending."March 14, 2024 | finance.yahoo.comGraphite Bio, Inc. (GRPH)March 10, 2024 | marketwatch.comGraphite Bio to Pay Special Dividend Linked to Lenz Therapeutics MergerMarch 8, 2024 | au.investing.comGraphite Bio announces $1.03 per share special dividendMarch 8, 2024 | msn.comGraphite Bio declares special $1.03 dividendMarch 8, 2024 | businesswire.comGraphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsFebruary 27, 2024 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHFebruary 13, 2024 | marketbeat.comShort Interest in Graphite Bio, Inc. (NASDAQ:GRPH) Decreases By 31.5%Graphite Bio, Inc. (NASDAQ:GRPH - Get Free Report) saw a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 801,800 shares, a decline of 31.5% from the January 15th total of 1,170,000 shares. Based on an average trading volume of 177,600 shares, the short-interest ratio is presently 4.5 days. Approximately 2.9% of the shares of the stock are short sold.February 2, 2024 | markets.businessinsider.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Graphite Bio, Inc. (GRPH)January 3, 2024 | marketbeat.comShort Interest in Graphite Bio, Inc. (NASDAQ:GRPH) Decreases By 6.0%Graphite Bio, Inc. (NASDAQ:GRPH - Get Free Report) saw a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 1,260,000 shares, a decline of 6.0% from the November 30th total of 1,340,000 shares. Based on an average daily trading volume, of 162,900 shares, the short-interest ratio is presently 7.7 days. Currently, 4.6% of the shares of the company are sold short.December 25, 2023 | seekingalpha.comGraphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 TrialDecember 16, 2023 | marketbeat.comShort Interest in Graphite Bio, Inc. (NASDAQ:GRPH) Rises By 8.9%Graphite Bio, Inc. (NASDAQ:GRPH - Get Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 1,340,000 shares, an increase of 8.9% from the November 15th total of 1,230,000 shares. Currently, 4.9% of the company's stock are short sold. Based on an average daily volume of 136,600 shares, the days-to-cover ratio is presently 9.8 days.November 27, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 40.00% to 7.14November 17, 2023 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 17, 2023 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 16, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ TherapeuticsNovember 16, 2023 | bizjournals.comShattered dream of sickle cell disease cure to end in reverse merger for Peninsula biotechNovember 16, 2023 | finance.yahoo.comWhat Makes Graphite Bio, Inc. (GRPH) a New Buy StockNovember 15, 2023 | benzinga.comGRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to ShareholdersNovember 15, 2023 | markets.businessinsider.comGraphite Bio To Merge With LENZ Therapeutics; Stock Down In Pre-marketNovember 15, 2023 | finance.yahoo.comLENZ Therapeutics and Graphite Bio Announce Merger AgreementNovember 15, 2023 | marketbeat.comTrading was temporarily halted for "GRPH" at 06:11 AM with a stated reason of "News pending."November 9, 2023 | morningstar.comGraphite Bio Inc GRPHNovember 1, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 25.00% to 5.10October 5, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 11.11% to 4.08September 12, 2023 | marketbeat.comBoard of Trustees of The Leland Stanford Junior University Purchases 243,784 Shares of Graphite Bio, Inc. (NASDAQ:GRPH)Board of Trustees of The Leland Stanford Junior University raised its stake in shares of Graphite Bio, Inc. (NASDAQ:GRPH - Free Report) by 53.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 703,071 sAugust 25, 2023 | marketbeat.comAldebaran Capital LLC Invests $318,000 in Graphite Bio, Inc. (NASDAQ:GRPH)Aldebaran Capital LLC bought a new position in Graphite Bio, Inc. (NASDAQ:GRPH - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 130,000 shares of the company's stock, valued at approximately $318,000.August 21, 2023 | marketbeat.comBrokers Set Expectations for Graphite Bio, Inc.'s FY2023 Earnings (NASDAQ:GRPH)Graphite Bio, Inc. (NASDAQ:GRPH - Free Report) - Equities research analysts at Cantor Fitzgerald dropped their FY2023 earnings per share estimates for shares of Graphite Bio in a research note issued on Thursday, August 17th. Cantor Fitzgerald analyst O. Brayer now anticipates that the company wiAugust 20, 2023 | marketbeat.comFederated Hermes Inc. Has $1 Million Holdings in Graphite Bio, Inc. (NASDAQ:GRPH)Federated Hermes Inc. lessened its stake in Graphite Bio, Inc. (NASDAQ:GRPH - Free Report) by 61.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 409,962 shares of the company's stock after selling 648,539 shares during theAugust 18, 2023 | marketbeat.comFY2023 EPS Estimates for Graphite Bio, Inc. (NASDAQ:GRPH) Decreased by AnalystGraphite Bio, Inc. (NASDAQ:GRPH - Free Report) - Equities research analysts at Leerink Partnrs cut their FY2023 earnings estimates for Graphite Bio in a research report issued to clients and investors on Tuesday, August 15th. Leerink Partnrs analyst M. Foroohar now anticipates that the company wiJune 23, 2023 | seekingalpha.comGraphite Bio CFO resigns to pursue other opportunitiesJune 23, 2023 | finance.yahoo.comGraphite Bio Announces Departure of Chief Financial OfficerJune 20, 2023 | marketbeat.comGraphite Bio, Inc. (NASDAQ:GRPH) Receives Average Recommendation of "Reduce" from AnalystsGraphite Bio, Inc. (NASDAQ:GRPH - Get Rating) has been given an average rating of "Reduce" by the nine brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and eight have assigned a hold rating to the comJune 9, 2023 | marketbeat.comEcoR1 Capital LLC Increases Stock Position in Graphite Bio, Inc. (NASDAQ:GRPH)EcoR1 Capital LLC raised its holdings in Graphite Bio, Inc. (NASDAQ:GRPH - Get Rating) by 261.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,712,096 shares of the company's stock after purchasMay 26, 2023 | marketbeat.comGraphite Bio, Inc. (NASDAQ:GRPH) Given Average Rating of "Reduce" by BrokeragesShares of Graphite Bio, Inc. (NASDAQ:GRPH - Get Rating) have received an average rating of "Hold" from the nine research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating and eight have given a hold rating to the company. TMay 19, 2023 | marketbeat.comFY2023 EPS Estimates for Graphite Bio, Inc. (NASDAQ:GRPH) Cut by AnalystGraphite Bio, Inc. (NASDAQ:GRPH - Get Rating) - Research analysts at Cantor Fitzgerald decreased their FY2023 earnings per share (EPS) estimates for Graphite Bio in a research report issued on Tuesday, May 16th. Cantor Fitzgerald analyst O. Brayer now forecasts that the company will post earningsMay 15, 2023 | markets.businessinsider.comSVB Securities Sticks to Their Hold Rating for Graphite Bio (GRPH)May 15, 2023 | finance.yahoo.comGraphite Bio, Inc.'s (NASDAQ:GRPH) largest shareholders are private equity firms with 43% ownership, institutions own 22%May 10, 2023 | finance.yahoo.comShould You Buy Graphite Bio (GRPH) Ahead of Earnings?May 1, 2023 | marketbeat.comGraphite Bio, Inc. (NASDAQ:GRPH) Given Average Recommendation of "Hold" by AnalystsGraphite Bio, Inc. (NASDAQ:GRPH - Get Rating) has been assigned a consensus recommendation of "Hold" from the nine brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation and eight have given a hold recommendation toApril 6, 2023 | marketbeat.comGraphite Bio, Inc. (NASDAQ:GRPH) Given Consensus Rating of "Hold" by AnalystsGraphite Bio, Inc. (NASDAQ:GRPH - Get Rating) has earned a consensus rating of "Hold" from the nine analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and eight have assigned a hold recommendation to the companyApril 1, 2023 | finanznachrichten.deNorthern Graphite Corporation: Northern Graphite Increases Size of Mousseau West ProjectMarch 25, 2023 | finance.yahoo.comWe're Keeping An Eye On Graphite Bio's (NASDAQ:GRPH) Cash Burn Rate Get Graphite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… GRPH Media Mentions By Week GRPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRPH News Sentiment▼0.000.57▲Average Medical News Sentiment GRPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRPH Articles This Week▼00▲GRPH Articles Average Week Get Graphite Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: XFOR News Today ELEV News Today CGEN News Today OPT News Today GNFT News Today CLLS News Today ZURA News Today ABOS News Today INMB News Today KOD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRPH) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsElon’s New Device is About to Shock the WorldInvestorPlaceWhat’s Really Next for America…Porter & CompanyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graphite Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
